Thebaine Market Growth Accelerated by Increased Use in Pain Management and Opioid Dependence



Thebaine is an opioid alkaloid obtained from opium poppies with analgesic, antitussive and potential utility in withdrawal management due to its unique receptor pharmacology. It is increasingly being used in various pharmaceutical preparations for pain management and treatment of opioid dependence.

The global Thebaine Market is estimated to be valued at US$ 45 million in 2023 and is expected to exhibit a CAGR of 1.5% over the forecast period 2023.

Market key trends:
Increased use of thebaine for pain management and opioid dependence treatment has been a major trend in the global thebaine market. The unique properties of thebaine allow its use in formulations for relief of moderate to severe pain with limited respiratory depressive effects and risk of addiction as compared to other opioids. Additionally, its antagonist activity facilitates blockade of euphoric effects of opioid agonists making it useful for treatment of opioid dependence. This dual mechanism of action has led pain management and addiction treatment to become leading application areas for thebaine contributing significantly to growth of the global market.

Segment Analysis

The thebaine market is segmented into extraction and synthesis, where extraction dominates currently. The extraction process uses the opium poppy plant to extract thebaine in its pure form, accounting for over 60% of the global market share. This process is preferred due to availability of raw materials and lower costs involved compared to the synthesis process. However, with stringent regulations around cultivation of opium poppy, the synthesis segment is expected to witness higher growth in the coming years.

Key Takeaways

The global thebaine market is expected to witness steady growth.

Regional analysis: North America currently dominates the global thebaine market with a share of over 35%, followed by Europe. This is attributed to presence of key manufacturers in these regions and stringent regulations around opioids. The Asia Pacific region is expected to witness highest growth during the forecast period with countries like China and India emerging as key manufacturers.

Key players operating in the thebaine market are Eli Lilly, Pfizer, Sanofi, Rohrer, Cipla, and Sun Pharma. Eli Lilly is the market leader with over 15% market share due to its wide product portfolio and R&D investments. Pfizer follows with strong focus on synthesis of controlled substances.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more